• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Fundraising

Biotech

Fierce Biotech Fundraising Tracker: Ribon, Grey Wolf and more

Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker.
Gabrielle Masson , Max Bayer , Annalee Armstrong Feb 6, 2023 11:36am

The rise of venture debt in biotech and when to use it

Jan 24, 2023 10:05am

Fierce Biotech Fundraising Tracker: Enveda, Enlaza and more

Dec 21, 2022 10:00am

FDA extends review of Gamida Cell's approval by 3 months

Nov 22, 2022 10:55am

FogPharma hauls in $178M series D

Nov 21, 2022 4:33pm

Jnana Therapeutics brings in $107M funds, $2B Roche collab

Nov 15, 2022 6:00am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy